SecBot SecBot
15-12G ·Filed Mar 2, 2026

ANEB

Anebulo Pharmaceuticals, Inc.
BEARISH
Impact 7/10
Horizondays Processed7mo ago SEC0001493152-26-008559
Deregistration
Actionable Insight ▼ Bearish

Monitor for potential OTC trading post-deregistration.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ANEB ▲ +37.72% at T+60d
SHORT call ✗ call lost -37.72% · α vs SPY -27.41% · entry $0.3340 → $0.4600
Entry = T+0 close
Mar 2, 2026
via day close
T+1d
+19.76%
call -19.76% · α -19.00%
$0.4000
settled 8mo ago
T+5d
+34.73%
call -34.73% · α -35.21%
$0.4500
settled 8mo ago
T+20d
+196.41%
call -196.41% · α -200.81%
$0.9900
settled 7mo ago
T+60d
+37.72%
call -37.72% · α -27.41%
$0.4600
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Anebulo Pharmaceuticals, Inc. (ANEB) has filed Form 15-12G to terminate the registration of its Common Stock under Section 12(g) of the Securities Exchange Act of 1934, effectively deregistering from the SEC and ceasing public reporting obligations. The company cites Rule 12g-4(a)(1) or (a)(2), indicating it has fewer than 300 shareholders of record, with approximately 71 holders as of the filing date. This 'going dark' move reduces transparency and liquidity for shareholders.

Key Facts

  • Anebulo Pharmaceuticals is terminating registration of its Common Stock under Section 12(g) of the Exchange Act.
  • Approximately 71 holders of record as of March 2, 2026, supporting deregistration under Rule 12g-4(a)(1) or (a)(2).
  • No classes of securities will remain subject to reporting under Sections 13(a) or 15(d).
  • Filing effective immediately as of March 2, 2026.
  • Company is not being acquired; deregistration is voluntary based on shareholder count.

Financial Impact

Loss of public reporting and Nasdaq listing likely to reduce liquidity and investor access; market cap of $15M suggests limited institutional interest. No direct financial transaction, but increased cost savings from reduced compliance.

transparencyliquidityshareholder basecompliance costs

Risk Factors

  • Significant reduction in transparency and disclosure for investors.
  • Potential delisting from Nasdaq and move to OTC markets, increasing bid-ask spreads and reducing liquidity.
  • Limited ability to conduct future public financings if needed.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
15-12G Filing (Primary)0001493152-26-008559
Document: 0001493152-26-008559-index-headers.html0001493152-26-008559
Document: 0001493152-26-008559-index.html0001493152-26-008559
Document: 0001493152-26-008559.txt0001493152-26-008559

US Market Status

Market Closed — Opens Wed (16h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026